HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Edward F. Parker John M. Kratz Amer Chaikhouni Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Parker, E. F. Articles by Bartles, D. M. Search for Related Content PubMed PubMed Citation Articles by Parker, E. F. Articles by Bartles, D. M.

Ann Thorac Surg 1985;40:121-125
© 1985 The Society of Thoracic Surgeons

---

Articles

Chemoradiation Therapy and Resection for Carcinoma of the Esophagus: Short-term Results

From the Division of Cardio-Thoracic Surgery and the Department of Radiation Therapy, Medical University of South Carolina and its affiliated hospitals (Medical University, Veterans Administration, and Charleston Memorial), Charleston, SC.

^* Address reprint requests to Dr. Parker, Medical University of South Carolina, Division of Cardio-Thoracic Surgery, 171 Ashley Ave, Charleston, SC 29425

The purpose of this report is to record the results of a treatment protocol for patients with carcinoma of the esophagus. In May, 1980, we initiated a program of chemoradiation therapy preliminary to resection in patients in whom the protocol was applicable. The chemotherapy consisted of mitomycin-C, 10 mg as a bolus intravenous injection on day 1, and 5-fluorouracil, 1,000 mg per square meter of body surface area in 1,000 ml of 5% glucose solution in distilled water given intravenously on each of days 1 through 4. The radiation therapy consisted of 3,000 rads in three weeks using cobalt 60 or 6 MeV or greater, with ports to cover the tumor and mediastinum. This protocol was given to patients with primary carcinoma of the esophagus whose disease remained or became operable during or following the course of the chemoradiation.

Among the patients treated according to the protocol, the operability rate was increased. The resectability rate remained about the same as in our previous experience. The operative mortality was lessened appreciably. The percentage of resected specimens of the esophagus showing residual tumor decreased. However, the absence of any residual tumor in the surgical specimen has not conferred any improved chance of long-term survival to date. There has been a two-year survival of 33% (7/21) among the small group having chemoradiation therapy prior to resection, and this figure is roughly the same as that in our previously reported series of patients treated by preoperative irradiation (4,500 rads in three weeks) and resection without the chemotherapeutic adjunct. The observations are short term, but 12 of 31 patients (39%) having chemoradiation therapy followed by resection are still alive. This may be an encouraging portent.

This article has been cited by other articles:

				E. F. Parker, R. D. Marks, J. M. Kratz, A. Chaikhouni, E. T. Warren, and D. M. Bartles Chemoradiation therapy and resection for carcinoma of the esophagus: Short-term results Ann. Thorac. Surg., October 1, 1992; 54(4): 808 - 808. [Abstract] [PDF]

				D. B. Skinner Technical and scientific advances in general thoracic surgery Ann. Thorac. Surg., January 1, 1990; 49(1): 14 - 25. [PDF]